Objectives   To compare the difference between China and India’s World Health Organization (WHO) Collaboration Center’s Cataract Surgery Strategy.

Methods  Comparison of man power details, surgery method, surgery consumable IOL resources, surgery Revenue, cataract Surgery case volume.

Results  There are more cataract doctors in Aravind hospital than Tongren Eye Center. Nearly all cataract patients are treated with Phacoemulsification (Phaco) in Tongren Eye Center. Aurolab provides the intraocular lens (IOL) for Aravind Eye Hospital; Beijing Tongren Eye Center and outreach programs’ patients use the IOL provided by various manufacturers. Out of all the patients in Aravind, only one third of them are paying patients. The revenue from those one third covers the cost for almost all the other non paying patients. A portion of the costs are covered by the government’s medical insurance plans in Tongren Eye Center. The cataract surgery numbers of Aravind hospital are far more than Tongren Eye Center.

Conclusions  Each of these two WHO collaboration centers has their own advantages. Different model of prevention and treatment of blindness depends on different medical and public health system. Aravind Eye Hospital and Tongren Hospital are both WHO collaboration center in developing countries so that comparing the difference is valuable to this field. By training more practiced cataract doctors，using appropriate surgery methods and cost controlling，it would be able to give more support to China Blindness Prevention.